Posted by Michael Wonder on 10 Feb 2017
Post-market review of pulmonary arterial hypertension medicines – public consultation
10 February 2017 - The public submission process is now open for the post-market review of pulmonary arterial hypertension medicines.
Interested organisations and individuals are invited to provide a submission addressing the Review’s Terms of Reference.
The public submission process will be open for 6 weeks and will close at 5 pm AEDT Monday, 27 March 2017.
